Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122253
Filing Date
2024-11-06
Accepted
2024-11-06 16:03:38
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20240930.htm   iXBRL 10-Q 2155113
2 EX-10.1 acet-ex10_1.htm EX-10.1 33947
3 EX-31.1 acet-ex31_1.htm EX-31.1 15576
4 EX-31.2 acet-ex31_2.htm EX-31.2 15706
5 EX-32.1 acet-ex32_1.htm EX-32.1 11959
  Complete submission text file 0000950170-24-122253.txt   8282565

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20240930.xsd EX-101.SCH 1412756
77 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240930_htm.xml XML 1143388
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 241430828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)